These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37242550)

  • 1. Natural Product-Based Screening for Lead Compounds Targeting SARS CoV-2 M
    Chen J; Zhou X; Fu L; Xu H
    Pharmaceuticals (Basel); 2023 May; 16(5):. PubMed ID: 37242550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on screening potential traditional Chinese medicines against 2019-nCoV based on Mpro and PLP].
    Ma J; Huo XQ; Chen X; Zhu WX; Yao MC; Qiao YJ; Zhang YL
    Zhongguo Zhong Yao Za Zhi; 2020 Mar; 45(6):1219-1224. PubMed ID: 32281328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Silico Screening of Potential Chinese Herbal Medicine Against COVID-19 by Targeting SARS-CoV-2 3CLpro and Angiotensin Converting Enzyme II Using Molecular Docking.
    Gao LQ; Xu J; Chen SD
    Chin J Integr Med; 2020 Jul; 26(7):527-532. PubMed ID: 32632717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Both Baicalein and Gallocatechin Gallate Effectively Inhibit SARS-CoV-2 Replication by Targeting M
    Xiao T; Cui M; Zheng C; Zhang P; Ren S; Bao J; Gao D; Sun R; Wang M; Lin J; Zhang L; Li M; Li D; Zhou H; Yang C
    Inflammation; 2022 Jun; 45(3):1076-1088. PubMed ID: 34822072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Network pharmacology, molecular docking integrated surface plasmon resonance technology reveals the mechanism of Toujie Quwen Granules against coronavirus disease 2019 pneumonia.
    Ye M; Luo G; Ye D; She M; Sun N; Lu YJ; Zheng J
    Phytomedicine; 2021 May; 85():153401. PubMed ID: 33191068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel inhibitor of SARS-CoV-2 3CL-PRO through virtual screening and molecular dynamics simulation.
    Bepari AK; Reza HM
    PeerJ; 2021; 9():e11261. PubMed ID: 33954055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential inhibitors of coronavirus 3-chymotrypsin-like protease (3CL
    Gyebi GA; Ogunro OB; Adegunloye AP; Ogunyemi OM; Afolabi SO
    J Biomol Struct Dyn; 2021 Jun; 39(9):3396-3408. PubMed ID: 32367767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Silico and In Vitro Identification of Pan-Coronaviral Main Protease Inhibitors from a Large Natural Product Library.
    Shahhamzehei N; Abdelfatah S; Efferth T
    Pharmaceuticals (Basel); 2022 Mar; 15(3):. PubMed ID: 35337106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virtual screening of natural products inspired in-house library to discover potential lead molecules against the SARS-CoV-2 main protease.
    Garg A; Goel N; Abhinav N; Varma T; Achari A; Bhattacharjee P; Kamal IM; Chakrabarti S; Ravichandiran V; Reddy AM; Gupta S; Jaisankar P
    J Biomol Struct Dyn; 2023 Mar; 41(5):2033-2045. PubMed ID: 35043750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Aloe-derived natural products as prospective lead scaffolds for SARS-CoV-2 main protease (M
    Hicks EG; Kandel SE; Lampe JN
    Bioorg Med Chem Lett; 2022 Jun; 66():128732. PubMed ID: 35427739
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Allam AE; Amen Y; Ashour A; Assaf HK; Hassan HA; Abdel-Rahman IM; Sayed AM; Shimizu K
    RSC Adv; 2021 Jun; 11(36):22398-22408. PubMed ID: 35480825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based virtual screening, in silico docking, ADME properties prediction and molecular dynamics studies for the identification of potential inhibitors against SARS-CoV-2 M
    Mohan A; Rendine N; Mohammed MKS; Jeeva A; Ji HF; Talluri VR
    Mol Divers; 2022 Jun; 26(3):1645-1661. PubMed ID: 34480682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-Pyridone natural products as inhibitors of SARS-CoV-2 main protease.
    Forrestall KL; Burley DE; Cash MK; Pottie IR; Darvesh S
    Chem Biol Interact; 2021 Feb; 335():109348. PubMed ID: 33278462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Silico Identification of New Anti-SARS-CoV-2 Main Protease (M
    Onyango H; Odhiambo P; Angwenyi D; Okoth P
    J Trop Med; 2022; 2022():3697498. PubMed ID: 36263438
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Wahab GA; Aboelmaaty WS; Lahloub MF; Sallam A
    RSC Adv; 2022 Jun; 12(29):18412-18424. PubMed ID: 35799933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening of plant-based natural compounds as a potential COVID-19 main protease inhibitor: an
    Majumder R; Mandal M
    J Biomol Struct Dyn; 2022 Feb; 40(2):696-711. PubMed ID: 32897138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Silico Screening of Potential Spike Glycoprotein Inhibitors of SARS-CoV-2 with Drug Repurposing Strategy.
    Wei TZ; Wang H; Wu XQ; Lu Y; Guan SH; Dong FQ; Dong CL; Zhu GL; Bao YZ; Zhang J; Wang GY; Li HY
    Chin J Integr Med; 2020 Sep; 26(9):663-669. PubMed ID: 32740825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-silico pharmacophoric and molecular docking-based drug discovery against the Main Protease (Mpro) of SARS-CoV-2, a causative agent COVID-19.
    Haider Z; Subhani MM; Farooq MA; Ishaq M; Khalid M; Akram MN; Khan RSA; Niazi AK
    Pak J Pharm Sci; 2020 Nov; 33(6):2697-2705. PubMed ID: 33867348
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Cheohen CFAR; Esteves MEA; da Fonseca TS; Leal CM; Assis FLF; Campos MF; Rebelo RS; Allonso D; Leitão GG; da Silva ML; Leitão SG
    Comput Struct Biotechnol J; 2023; 21():1461-1472. PubMed ID: 36817956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 proteases Mpro and PLpro: Design of inhibitors with predicted high potency and low mammalian toxicity using artificial neural networks, ligand-protein docking, molecular dynamics simulations, and ADMET calculations.
    Tumskiy RS; Tumskaia AV; Klochkova IN; Richardson RJ
    Comput Biol Med; 2023 Feb; 153():106449. PubMed ID: 36586228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.